12-82358746-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032230.3(METTL25):c.181G>T(p.Ala61Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,614,006 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A61G) has been classified as Uncertain significance.
Frequency
Consequence
NM_032230.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
METTL25 | NM_032230.3 | c.181G>T | p.Ala61Ser | missense_variant | 1/12 | ENST00000248306.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
METTL25 | ENST00000248306.8 | c.181G>T | p.Ala61Ser | missense_variant | 1/12 | 1 | NM_032230.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152260Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250616Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135602
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461746Hom.: 0 Cov.: 36 AF XY: 0.00000413 AC XY: 3AN XY: 727170
GnomAD4 genome AF: 0.000105 AC: 16AN: 152260Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74390
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 13, 2023 | The c.181G>T (p.A61S) alteration is located in exon 1 (coding exon 1) of the METTL25 gene. This alteration results from a G to T substitution at nucleotide position 181, causing the alanine (A) at amino acid position 61 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at